title: Pharmaco-EEG Studies in Animals: An Overview of Contemporary Translational Applications.
abstract: The contemporary value of animal pharmaco-electroencephalography (p-EEG)-based applications are strongly interlinked with progress in recording and neuroscience analysis methodology. While p-EEG in humans and animals has been shown to be closely related in terms of underlying neuronal substrates, both translational and back-translational approaches are being used to address extrapolation issues and optimize the translational validity of preclinical animal p-EEG paradigms and data. Present applications build further on animal p-EEG and pharmaco-sleep EEG findings, but also on stimulation protocols, more specifically pharmaco-event-related potentials. Pharmaceutical research into novel treatments for neurological and psychiatric diseases has employed an increasing number of pharmacological as well as transgenic models to assess the potential therapeutic involvement of different neurochemical systems and novel drug targets as well as underlying neuronal connectivity and synaptic function. Consequently, p-EEG studies, now also readily applied in modeled animals, continue to have an important role in drug discovery and development, with progressively more emphasis on its potential as a central readout for target engagement and as a (translational) functional marker of neuronal circuit processes underlying normal and pathological brain functioning. In a similar vein as was done for human p-EEG studies, the contribution of animal p-EEG studies can further benefit by adherence to guidelines for methodological standardization, which are presently under construction by the International Pharmaco-EEG Society (IPEG).
authors.forename: Wilhelmus H I M
authors.initials: WH
authors.lastname: Drinkenburg
authors.forename: Gé S F
authors.initials: GS
authors.lastname: Ruigt
authors.forename: Abdallah
authors.initials: A
authors.lastname: Ahnaou
mesh_terms: D000818:Animals; D058256:Brain Waves / Q000187:drug effects; D002491:Central Nervous System Agents / Q000494:pharmacology* / Q000627:therapeutic use; D004195:Disease Models, Animal; D004569:Electroencephalography; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000503:physiopathology*; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology*; D057170:Translational Research, Biomedical / Q000295:instrumentation / Q000379:methods
chemical_list: D002491:Central Nervous System Agents